Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study
Conditions: Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Hormone Receptor-Positive Breast Carcinoma Interventions: Other: Best Practice; Procedure: Biospecimen Collection; Procedure: Endocrine Drug Therapy; Behavioral: Health Education; Other: Questionnaire Administration; Other: Symptom Specific Assessment Tool Sponsors: Southwest Oncology Group; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2022 Category: Research Source Type: clinical trials
A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide
Condition: Biochemically Recurrent Prostate Cancer Interventions: Drug: Darolutamide(BAY1841788, Nubeqa); Drug: Enzalutamide Sponsor: Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 2, 2022 Category: Research Source Type: clinical trials
